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How useful are autoantibodies  
in diagnosing thyroid disorders? 
Evidence-based answer
they’re	useful	in	diagnosing	Graves’	
disease	and,	to	a	lesser	extent,	
autoimmune	thyroid	disease;	they	can	also	
help	predict	hypothyroidism.	thyrotropin	
receptor	antibodies	(trAb)	may	be	mildly	
elevated	in	a	variety	of	thyroid	disorders,	
but	a	trAb	level	>10	u/l	increases	
the	probability	of	Graves’	disease	by	
a	moderate	to	large	degree	(strength	
of	recommendation	[sor]:	B,	cross-
sectional	study).	A	positive	or	negative	
thyroid	peroxidase	antibody	(tpoAb)	test	
increases	or	decreases	the	probability	
of	autoimmune	thyroid	disease	by	only	
a	small	to	moderate	degree	(sor:	B,	3	
cross-sectional	studies).	
	 thyroid-stimulating	hormone	(tsH)	
levels	>2	mu/l,	although	still	in	the	normal	
range,	can	be	followed	up	with	tpoAb	
testing	to	determine	whether	the	patient	
has	an	increased	probability	of	developing	
hypothyroidism	(sor:	B,	cohort	study	
with	a	vague	hypothyroidism	reference	
standard).	
Clinical commentary
In equivocal situations and pregnancy, 
antibodies may help
under	most	circumstances,	hypo-	and	
hyperthyroid	disorders	can	be	diagnosed	
by	testing	tsH	and	free	t4,	without	thyroid	
antibody	testing.	radionuclide	uptake	and	
scan	provide	diagnostic	information	for	
hyperthyroid	states.	
	 thyroid	antibody	tests	may	help	in	
equivocal	situations,	such	as	a	normal	
radioiodine	study	in	hyperthyroidism	or	
evaluating	the	cause	of	hypothyroidism	when	
infiltrative	disorders,	reidel’s	thyroiditis,	
or	subacute	granulomatous	thyroiditis	are	
suspected.	tpoAb	may	help	predict	the	
development	of	clinical	hypothyroidism	in	
patients	with	tsH	in	the	range	of	5-10	mu/l.	
	 pregnancy-related	hyperthyroidism	
requires	antibody	testing	because	
radioiodine	scans	are	contraindicated.	
Antibody	titers	also	may	estimate	the	risk	
of	pregnancy-related	adverse	outcomes.
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z  Evidence summary
Although TSH followed by free T4 re-
main the initial screening tests for thyroid 
disorders, adding thyroid autoantibodies 
may refine the diagnosis. Three princi-
pal thyroid antibodies—TPOAb, thyro-
globulin, and TRAb—can be positive in 
a variety of autoimmune thyroid disor-
ders. TPOAb represents a specific antigen 
of antimicrosomal antibody (AMA). It 
has largely replaced AMA testing in most 
laboratories and clinical settings. 
Antibodies point to Graves’,  
autoimmune disorders 
A cross-sectional study of 267 Singa-
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porean patients with previously diag-
nosed thyroid disorders measured TRAb, 
AMA, and thyroglobulin (TABLE). TRAb 
levels >10 U/L were found to have a posi-
tive likelihood ratio (LR+) of 13 and a 
negative likelihood ratio (LR−) of 0.2 for 
Graves’ disease.1 
Two cross-sectional studies com-
pared AMA to TPOAb in healthy patients 
and those with autoimmune thyroid and 
nonthyroid disorders. One study of 235 
people in a university endocrinology 
department found that a TPOAb level 
>190 U/mL yielded an LR+ of 10.75 and 
an LR− of 0.15 for chronic autoimmune 
(Hashimoto’s) thyroiditis [CAHT]; the 
AMA-positive sera yielded an LR+ of 
13.67 and an LR− of 0.19. Both TPOAb 
and AMA test characteristics were highly 
associated with CAHT (P<.001). 
TPOAb is more sensitive  
than AMA and thyroglobulin
In the second study comparing AMA to 
TPOAb, the thyroid antibody test results 
of 32 healthy patients were compared 
with those of 262 clinic patients. In those 
with known thyroid dysfunction, TPOAb 
was found to be a more sensitive assay 
than AMA for autoimmune thyroid dis-
orders. The sensitivity of TPOAb levels 
>3.1 U/mL was 88.1%; AMA sensitivity 
was 70.2% (P<.001).2,3 
A cross-sectional study (National 
Health and Nutrition Examination Sur-
vey [NHANES III]) evaluated the pres-
ence of thyroid antibodies in 17,353 
people representing the geographic and 
ethnic distribution of the United States, 
95% of whom were categorized as free 
of thyroid disease.4 The study found that 
TPOAb was more sensitive than thyro-
globulin for diagnosing nonspecific thy-
roid disease. The diagnosis of thyroid 
disease was based on abnormal TSH and 
free T4 levels. Abnormally high levels of 
TPOAb had an LR+ of 4.3 and LR− of 
0.6 (P<.0001) for thyroid disease, com-
pared with an LR+ of 3.4 and LR− of 0.7 
(P<.01) for abnormally elevated thyro-
globulin.
TSH + TPOAb more accurate  
than TSH in women
In the early 1970s, a cohort study of 2779 
adults from Great Britain attempted to es-
tablish the incidence of thyroid disease in 
the general population by measuring TSH 
and TPOAb. Twenty years later, investiga-
tors restudied 1708 people from the origi-
nal sample to determine the incidence of 
hypothyroidism and the prognostic value 
of these 2 biochemical markers for its de-
velopment. At follow-up, the definition of 
a new case of hypothyroidism was based 
on an “intention to treat by the general 
practitioner by meeting clear biochemical 
criteria and/or symptoms.” 
Autoimmune markers in thyroid disorders
ThyroId  
dIsordErs
 % of 
sTudy 
PaTIEnTs 
% Trab 
>3.4 u/l
% Trab 
>10 u/l
% ama 
PosITIvE
% ThyrogloBulIn 
PosITIvE
lr+ lr- lr+ lr- lr+ lr- lr+ lr-
graves’ disease 68 4.6 0.1 13 0.2 1.3 0.6 1.1 0.9
CahT 20 0.2 4.7 0.1 2.8 1.4 0.2 1.4 0.6
subacute  
thyroiditis
4 0.2 3.0 0 2.4 0.1 3.6 0.5 1.5
Thyroid nodules 6 0.2 3.4 0 2.4 0.1 4.1 0.1 2.0
others 2 0.8 1.4 0 2.3 0 2.8 0 2.0
AmA,	antimicrosomal	antibodies;	CAHt,	chronic	autoimmune	(Hashimoto’s)	thyroiditis;	lr+,	positive	likelihood	ratio;	lr-,	negative	likelihood	ratio;	trAb,	
thyrotropin	receptor	antibodies
source:	Khoo	DHC,	et	al.1	
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The initial presence of abnormally high 
serum TPOAb levels and TSH >2.0 mU/L pre-
dicted a 4.3% annual risk of developing hypo-
thyroidism compared with a 2.6% annual risk 
with serum TSH >6.0 mU/L alone in women. 
This risk was not estimated for men because of 
the small number of cases.5 
Recommendations
The American Association of Clinical Endo-
crinologists (AACE) makes no specific recom-
mendations about laboratory testing of thyroid 
antibodies. Based on clinical judgment, the 
AACE states that antibodies may be considered 
in the workup of hyperthyroidism and hypo-
thyroidism and to determine potential risk to 
the fetus in pregnant women diagnosed with 
Graves’ disease.6 
The National Academy of Clinical Bio-
chemistry (NACB) recommends TPOAb mea-
surements in patients who have Down syn-
drome, are pregnant, or have miscarried or 
failed in vitro fertilization. The NACB also 
advocates measuring TPOAb before treatment 
with amiodarone, lithium, interferon-α, or in-
terleukin-2.7 n
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